Clinicopathological association of CD93 expression in gastric adenocarcinoma
Journal of Cancer Research and Clinical Oncology · 2024
DOI: 10.1007/s00432-024-05874-4 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Cancer Research and Clinical Oncology, 2024. Verfasst von Yun Shen und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, People's Hospital of Tongling City, Tongling, Anhui, China. Hauptthemen laut MEDLINE: Stomach Neoplasms, Adenocarcinoma, Receptors, Complement. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Graduate Practice and Innovation Project of Shanxi Province, Key Research and Development projects in Shanxi Province, the Four "Batches" Innovation Project of Invigorating Medical through Science and Technology of Shanxi Province.
Abstract (Originalsprache)
Aims
CD93 was recently identified as a promising therapeutic target for angiogenesis blockade in various tumors. Herein, we aimed to investigate the expression and clinicopathological significance of CD93 in gastric adenocarcinoma.
Methods
The gene expression of CD93 gastric adenocarcinoma was assessed using The Cancer Genome Atlas (TCGA) dataset. We then analyzed CD93 expression in 404 cases of gastric adenocarcinoma using immunohistochemistry. Clinicopathological associations and prognostic implications of CD93 expression were further investigated.
Results
Using the TCGA dataset, we observed a significantly elevated CD93 gene expression in gastric adenocarcinoma compared to normal gastric tissues. The immunohistochemistry assay revealed a highly variable CD93 expression among patients with gastric adenocarcinoma, consistently demonstrating higher intratumor expression than in adjacent normal tissues. Notably, CD93 was predominantly expressed on the membrane of CD31 + vascular endothelial cells. Furthermore, patients with higher CD93 expression demonstrated significantly poorer overall survival. Accordingly, higher CD93 expression was associated with deeper invasion and a higher possibility of lymph node metastasis and developing tumor thrombus. Cox proportional hazards regression suggested CD93 expression was an independent predictor for the prognosis of patients with gastric adenocarcinoma.
Conclusions
Our study revealed a significantly higher CD93 expression in gastric adenocarcinoma when compared with adjacent normal gastric tissues, and demonstrated its predominant expression on vascular endothelial cells. Our findings also highlighted the clinicopathological significance of CD93 in gastric adenocarcinoma, shedding light on a potential therapeutic target.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pathology, People's Hospital of Tongling City, Tongling, Anhui, China.
- Department of Pathology, Heping Hospital Affiliated to Changzhi Medical College, Changzhi, Shanxi, China.
- Department of Pathology, the First Clinical College of Changzhi Medical College, No.161 Jiefang East Street, Changzhi, Shanxi, China.
- Department of Pathology, Yueyang Central Hospital, Yueyang, Hunan, China.
- Department of Pathology, Heping Hospital Affiliated to Changzhi Medical College, Changzhi, Shanxi, China. wjsczmc@163.com.
- Department of Pathology, the First Clinical College of Changzhi Medical College, No.161 Jiefang East Street, Changzhi, Shanxi, China. wjsczmc@163.com.
Förderung
- Graduate Practice and Innovation Project of Shanxi Province
- Key Research and Development projects in Shanxi Province
- the Four "Batches" Innovation Project of Invigorating Medical through Science and Technology of Shanxi Province
- the Four “Batches” Innovation Project of Invigorating Medical through Science and Technology of Shanxi Province
Zitieren
APA
Shen, Y., Wu, Y., Hao, M., Fu, M., Zhu, K., Luo, P., & Wang, J. (2024). Clinicopathological association of CD93 expression in gastric adenocarcinoma. Journal of Cancer Research and Clinical Oncology. https://doi.org/10.1007/s00432-024-05874-4
Vancouver
Shen Y, Wu Y, Hao M, Fu M, Zhu K, Luo P, et al. Clinicopathological association of CD93 expression in gastric adenocarcinoma. Journal of Cancer Research and Clinical Oncology. 2024. doi:10.1007/s00432-024-05874-4
BibTeX
@article{Shen2024,
author = {Shen, Yun and Wu, Yahui and Hao, Mengfei and Fu, Minghan and Zhu, Kai and Luo, Panru and Wang, Jinsheng},
title = {Clinicopathological association of CD93 expression in gastric adenocarcinoma},
journal = {Journal of Cancer Research and Clinical Oncology},
year = {2024},
doi = {10.1007/s00432-024-05874-4}
}
EUVIMED